Item request has been placed! ×
Item request cannot be made. ×
loading  Processing Request

Associations of metabolic changes and polygenic risk scores with cardiovascular outcomes and all-cause mortality across BMI categories: a prospective cohort study.

Item request has been placed! ×
Item request cannot be made. ×
loading   Processing Request
  • معلومة اضافية
    • المصدر:
      Publisher: BioMed Central Country of Publication: England NLM ID: 101147637 Publication Model: Electronic Cited Medium: Internet ISSN: 1475-2840 (Electronic) Linking ISSN: 14752840 NLM ISO Abbreviation: Cardiovasc Diabetol Subsets: MEDLINE
    • بيانات النشر:
      Original Publication: London : BioMed Central, [2002-
    • الموضوع:
    • نبذة مختصرة :
      Background: Associations between metabolic status and metabolic changes with the risk of cardiovascular outcomes have been reported. However, the role of genetic susceptibility underlying these associations remains unexplored. We aimed to examine how metabolic status, metabolic transitions, and genetic susceptibility collectively impact cardiovascular outcomes and all-cause mortality across diverse body mass index (BMI) categories.
      Methods: In our analysis of the UK Biobank, we included a total of 481,576 participants (mean age: 56.55; male: 45.9%) at baseline. Metabolically healthy (MH) status was defined by the presence of < 3 abnormal components (waist circumstance, blood pressure, blood glucose, triglycerides, and high-density lipoprotein cholesterol). Normal weight, overweight, and obesity were defined as 18.5 ≤ BMI < 25 kg/m 2 , 25 ≤ BMI < 30 kg/m 2 , and BMI ≥ 30 kg/m 2 , respectively. Genetic predisposition was estimated using the polygenic risk score (PRS). Cox regressions were performed to evaluate the associations of metabolic status, metabolic transitions, and PRS with cardiovascular outcomes and all-cause mortality across BMI categories.
      Results: During a median follow-up of 14.38 years, 31,883 (7.3%) all-cause deaths, 8133 (1.8%) cardiovascular disease (CVD) deaths, and 67,260 (14.8%) CVD cases were documented. Among those with a high PRS, individuals classified as metabolically healthy overweight had the lowest risk of all-cause mortality (hazard ratios [HR] 0.70; 95% confidence interval [CI] 0.65, 0.76) and CVD mortality (HR 0.57; 95% CI 0.50, 0.64) compared to those who were metabolically unhealthy obesity, with the beneficial associations appearing to be greater in the moderate and low PRS groups. Individuals who were metabolically healthy normal weight had the lowest risk of CVD morbidity (HR 0.54; 95% CI 0.51, 0.57). Furthermore, the inverse associations of metabolic status and PRS with cardiovascular outcomes and all-cause mortality across BMI categories were more pronounced among individuals younger than 65 years (P interaction  < 0.05). Additionally, the combined protective effects of metabolic transitions and PRS on these outcomes among BMI categories were observed.
      Conclusions: MH status and a low PRS are associated with a lower risk of adverse cardiovascular outcomes and all-cause mortality across all BMI categories. This protective effect is particularly pronounced in individuals younger than 65 years. Further research is required to confirm these findings in diverse populations and to investigate the underlying mechanisms involved.
      (© 2024. The Author(s).)
    • References:
      Curr Hypertens Rev. 2020;16(1):12-18. (PMID: 30987573)
      Arch Intern Med. 2008 Aug 11;168(15):1617-24. (PMID: 18695075)
      J Am Coll Cardiol. 2007 Jan 30;49(4):403-14. (PMID: 17258085)
      Circulation. 2009 Oct 20;120(16):1640-5. (PMID: 19805654)
      J Am Heart Assoc. 2021 Nov 16;10(22):e022502. (PMID: 34755533)
      BMC Med Res Methodol. 2018 Dec 22;18(1):176. (PMID: 30577770)
      J Clin Med. 2019 Aug 15;8(8):. (PMID: 31443279)
      Lancet. 2022 Sep 10;400(10355):811-821. (PMID: 36088949)
      Arterioscler Thromb Vasc Biol. 2023 Jul;43(7):1324-1333. (PMID: 37199161)
      PLoS Med. 2015 Mar 31;12(3):e1001779. (PMID: 25826379)
      Stroke. 2013 Sep;44(9):2451-6. (PMID: 23868276)
      Lancet Diabetes Endocrinol. 2018 Sep;6(9):714-724. (PMID: 29859908)
      JAMA Cardiol. 2021 Apr 1;6(4):437-447. (PMID: 33471027)
      J Am Coll Cardiol. 2018 May 1;71(17):1857-1865. (PMID: 29699611)
      Metabolism. 2019 Apr;93:18-24. (PMID: 30639450)
      Arch Intern Med. 2008 Aug 11;168(15):1609-16. (PMID: 18695074)
      Gigascience. 2019 Jul 1;8(7):. (PMID: 31307061)
      Circulation. 2010 Jan 19;121(2):230-6. (PMID: 20038741)
      Eur J Prev Cardiol. 2023 Oct 26;30(15):1676-1685. (PMID: 37228091)
      Eur Heart J. 2021 Mar 1;42(9):919-933. (PMID: 33532862)
      Atherosclerosis. 2022 May;348:16-24. (PMID: 35390551)
      Diabetes Care. 2001 Apr;24(4):683-9. (PMID: 11315831)
      Med Rev (2021). 2022 Feb 14;1(2):129-149. (PMID: 37724297)
      JCI Insight. 2020 Aug 20;5(16):. (PMID: 32663197)
      BMJ. 2006 Apr 15;332(7546):878-82. (PMID: 16510492)
      J Epidemiol Community Health. 2016 Oct;70(10):1024-31. (PMID: 27126492)
      Geroscience. 2022 Jun;44(3):1479-1488. (PMID: 35306636)
      Eur J Prev Cardiol. 2016 Jun;23(9):956-66. (PMID: 26701871)
      Nutrients. 2023 Feb 08;15(4):. (PMID: 36839222)
      Genome Med. 2018 Dec 27;10(1):100. (PMID: 30591078)
      Ann Intern Med. 2013 Dec 3;159(11):758-69. (PMID: 24297192)
      Nutr Metab Cardiovasc Dis. 2023 Jul;33(7):1349-1357. (PMID: 37156665)
      Nat Commun. 2020 Jan 9;11(1):163. (PMID: 31919418)
      JAMA. 2002 Dec 4;288(21):2709-16. (PMID: 12460094)
      Eur J Prev Cardiol. 2023 May 9;30(7):593-600. (PMID: 36757396)
      J Am Coll Cardiol. 2017 Sep 19;70(12):1429-1437. (PMID: 28911506)
      Int J Obes (Lond). 2019 Sep;43(9):1803-1810. (PMID: 30158567)
      Nat Genet. 2018 Apr;50(4):524-537. (PMID: 29531354)
      Lancet. 2012 Mar 31;379(9822):1173-4. (PMID: 22463865)
      J Am Coll Cardiol. 2020 Dec 22;76(25):2982-3021. (PMID: 33309175)
    • Grant Information:
      2017YFE0118800 the National Key Research and Development Program of China
    • Contributed Indexing:
      Keywords: All-cause mortality; Cardiovascular disease; Metabolic change; Metabolic health; Metabolic syndrome; Polygenic risk scores
    • الموضوع:
      Date Created: 20240704 Date Completed: 20240705 Latest Revision: 20240813
    • الموضوع:
      20240814
    • الرقم المعرف:
      PMC11225301
    • الرقم المعرف:
      10.1186/s12933-024-02332-w
    • الرقم المعرف:
      38965592